These services offer quick, affordable access to licensed doctors who can evaluate your health, discuss treatment options, and prescribe medications when appropriate
Learn about these distinctions in our compounding pharmacy vs research peptide analysis
Tirzepatide is a first-in-class dual incretin receptor agonist a single molecule that activates both the GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 (glucagon-like peptide-1) receptors, which is why it is often nicknamed a twincretin. [7] By engaging two incretin pathways it enhances glucose-dependent insulin secretion, promotes satiety, and delays gastric emptying, producing large effects on both glycemic control and bodyweight
It can be purchased through LillyDirect for $449/month without insurance
Has this specific three-peptide combination been studied together
Clinical evidence from the SURMOUNT trials demonstrated that tirzepatide produces weight losses ranging from 21% to 22.5% of baseline body weight at the highest maintenance dose, representing outcomes significantly greater than older GLP-1 monotherapy agents
